Phio Pharmaceuticals Announces Two Upcoming Data Presentations at Scientific Conferences in October 2021

On September 30, 2021 Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic platform, reported two poster presentations at upcoming scientific conferences scheduled to take place in October 2021 (Press release, Phio Pharmaceuticals, SEP 30, 2021, View Source [SID1234590578]). These presentations include an abstract being presented by the Phio team at the AACR (Free AACR Whitepaper)-NCI-EORTC Virtual AACR-NCI-EORTC (Free AACR-NCI-EORTC Whitepaper) International Conference on Molecular Targets and Cancer Therapeutics (EORTC-NCI-AACR) (Free ASGCT Whitepaper) (Free EORTC-NCI-AACR Whitepaper), which is being held from October 7-10, 2021; and a poster presentation of data from a study using INTASYL by the Company’s collaborators at Helmholtz Zentrum München (HMGU) at the 8th Immunotherapy of Cancer (SITC) (Free SITC Whitepaper) Conference (ITOC8), which is being held from Oct. 8–9, 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details are as follows:

Event: AACR (Free AACR Whitepaper)-NCI-EORTC Virtual AACR-NCI-EORTC (Free AACR-NCI-EORTC Whitepaper) International Conference on Molecular Targets and Cancer Therapeutics (EORTC-NCI-AACR) (Free ASGCT Whitepaper) (Free EORTC-NCI-AACR Whitepaper)
Title: Targeting BRD4 in T cells with self-delivering RNAi PH-894 for immunotherapy
Authors: Melissa Maxwell, et al.
Date: October 7-10, 2021

An archived version of the Phio presentation will be made available on the "Investors – Events and Presentations" section of the Company’s website (click here).

Event: 8th Immunotherapy of Cancer (SITC) (Free SITC Whitepaper) Conference (ITOC8)
Title: Targeting Diaclyglycerol Kinase alpha and zeta by self-delivering RNAi to optimize T lymphocytes for adoptive therapy of solid tumors
Authors: Anna Herbstritt, et al.
Abstract Number: P01.03
Date: October 8-9, 2021